Risk prediction model for cisplatin-induced acute kidney injury in patients with head and neck cancer receiving chemoradiotherapy: A re-analysis of a phase II/III JCOG1008 trial.
Imamura Y, Kiyota N, Tahara M, Kodaira T, Hayashi R, Nishino H, Asada Y, Mitani H, Iwae S, Nishio N, Onozawa Y, Hanai N, Ohkoshi A, Hara H, Monden N, Nagaoka M, Minami S, Kitabayashi R, Sasaki K, Homma A; Head, Neck Cancer Study Group of the Japan Clinical Oncology Group (JCOG-HNCSG).
Imamura Y, et al. Among authors: hara h.
Oral Oncol. 2024 May 30;154:106868. doi: 10.1016/j.oraloncology.2024.106868. Online ahead of print.
Oral Oncol. 2024.
PMID: 38820889